Your browser doesn't support javascript.
loading
Immunoinformatics Approach to Design a Novel Epitope-Based Oral Vaccine Against Helicobacter pylori.
Urrutia-Baca, Victor Hugo; Gomez-Flores, Ricardo; De La Garza-Ramos, Myriam Angélica; Tamez-Guerra, Patricia; Lucio-Sauceda, Daniela Guadalupe; Rodríguez-Padilla, María Cristina.
Afiliação
  • Urrutia-Baca VH; Laboratory of Immunology and Virology, School of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico.
  • Gomez-Flores R; Laboratory of Immunology and Virology, School of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico.
  • De La Garza-Ramos MA; Integral Dentistry Unit and Specialties, Center for Research and Development in Health Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico.
  • Tamez-Guerra P; Laboratory of Immunology and Virology, School of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico.
  • Lucio-Sauceda DG; Laboratory of Immunology and Virology, School of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico.
  • Rodríguez-Padilla MC; Laboratory of Immunology and Virology, School of Biological Sciences, Autonomous University of Nuevo Leon, Monterrey, Mexico.
J Comput Biol ; 26(10): 1177-1190, 2019 10.
Article em En | MEDLINE | ID: mdl-31120321
Helicobacter pylori is an infectious agent that colonizes the gastric mucosa of half of the population worldwide. This bacterium has been recognized as belonging to group 1 carcinogen by the World Health Organization for the role in development of gastritis, peptic ulcers, and cancer. Due to the increase in resistance to antibiotics used in the anti-H. pylori therapy, the development of an effective vaccine is an alternative of great interest, which remains a challenge. Therefore, a rational, strategic, and efficient vaccine design against H. pylori is necessary where the use of the most current bioinformatics tools could help achieve it. In this study, immunoinformatics approach was used to design a novel multiepitope oral vaccine against H. pylori. Our multiepitope vaccine is composed of cholera toxin subunit B (CTB) that is used as a mucosal adjuvant to enhance vaccine immunogenicity for oral immunization. CTB fused to 11 epitopes predicted of pathogenic (UreB170-189, VacA459-478, CagA1103-1122, GGT106-126, NapA30-44, and OipA211-230) and colonization (HpaA33-52, FlaA487-506, FecA437-456, BabA129-149, and SabA540-559) proteins from H. pylori. CKS9 peptide (CKSTHPLSC) targets epithelial microfold cells to enhance vaccine uptake from the gut barrier. All sequences were joined to each other by proper linkers. The vaccine was modeled and validated to achieve a high-quality three-dimensional structure. The vaccine design was evaluated as nonallergenic, antigenic, soluble, and with an appropriate molecular weight and isoelectric point. Our results suggest that our newly designed vaccine could serve as a promising anti-H. pylori vaccine candidate.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Vacinas Bacterianas / Helicobacter pylori / Infecções por Helicobacter / Epitopos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Comput Biol Assunto da revista: BIOLOGIA MOLECULAR / INFORMATICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Vacinas Bacterianas / Helicobacter pylori / Infecções por Helicobacter / Epitopos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: J Comput Biol Assunto da revista: BIOLOGIA MOLECULAR / INFORMATICA MEDICA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: México País de publicação: Estados Unidos